Enzoduce-D Tablet
Marketer
Aberdure Pharma
Salt Composition
Bromelain (90mg) + Diclofenac (50mg) + Rutoside (100mg) + Trypsin Chymotrypsin (48mg)
Overview Enzoduce-D Tablet
Dolprin-D tablets offer relief from pain and inflammation. This medication is indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. It also provides relief from muscular aches, back pain, dental pain, and ear/throat discomfort. Dolprin-D should be administered with food to minimize gastrointestinal upset. Dosage is determined by the specific condition and treatment response, always following your physician's instructions. Never exceed the prescribed dosage or duration. Commonly reported side effects include nausea, vomiting, indigestion, diarrhea, abdominal pain, and appetite suppression. Report any persistent or worsening side effects to your doctor; they may offer strategies to mitigate them. Prior to commencing treatment, inform your doctor of any pre-existing stomach ulcers or bleeding, hypertension, or cardiac, renal, or hepatic impairment. Complete disclosure of all other medications is crucial, as interactions are possible. Consult your doctor before using Dolprin-D if pregnant, breastfeeding, or if you consume alcohol, as alcohol may potentiate drowsiness.
Uses of Enzoduce-D Tablet
Analgesia
Major Benefits of Enzoduce-D Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Enzoduce-D Tablet with a meal.
Common Side effects of Enzoduce-D Tablet:
- Nausea
- Vomiting
- Heartburn
- Diarrhea
- Stomach pain
- Loss of appetite
- Indigestion
How to use Enzoduce-D Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Enzoduce-D Tablet with a meal.
How Enzoduce-D Tablet works:
Enzoduce-D Tablet integrates four active components: bromelain, diclofenac, rutoside, and trypsin-chymotrypsin. The enzymes bromelain and trypsin-chymotrypsin enhance circulation and stimulate the body's natural anti-inflammatory and analgesic responses. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of prostaglandins, inflammatory mediators responsible for pain and swelling. Rutoside, possessing antioxidant properties, counteracts free radical damage, contributing to reduced inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Enzoduce-D Tablet with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Enzoduce-D tablets during pregnancy is strongly discouraged due to documented harm to the unborn child. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known risks. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Enzoduce-D Tablet use while breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Enzoduce-D Tablet side effects. Some individuals taking Enzoduce-D Tablet experience headaches, blurred vision, dizziness, or drowsiness; these symptoms can negatively impact driving capabilities.
KidneySAFE IF PRESCRIBED
The use of Enzoduce-D Tablets in individuals with kidney disease appears to pose minimal risk. Preliminary findings indicate that dose modification may not be necessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Enzoduce-D Tablets in individuals with liver impairment appears to present a low risk. Current evidence indicates dose modification may not be necessary, however, physician consultation is advised.
What if you forget to take Enzoduce-D Tablet :
NA
Facts to Know About Enzoduce-D Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Medication for pain relief |



